<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for FRX</title>
    <link />
    <description>Headlines for Forest Laboratories, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Forest to Present Aclidinium Bromide and Roflumilast Clinical Data at the American Thoracic Society</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/17/forest-to-present-aclidinium-bromide-and-roflumila/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 17 May 2013 08:21:04 GMT</pubDate>
    </item>
    <item>
      <title>Forest Laboratories, Inc. to Present Data from Cariprazine and Levomilnacipran Phase 3 Trials at Ame</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/16/forest-laboratories-inc-to-present-data-from-carip/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 16 May 2013 08:19:41 GMT</pubDate>
    </item>
    <item>
      <title>Forest Labs Will Present Data from Cariprazine and Levomilnacipran Phase 3 Trials at American Psychi</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3595759/forest-labs-will-present-data-from-cariprazine-and-levomilnacipran-phase-3-trials.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Thu, 16 May 2013 08:01:46 GMT</pubDate>
    </item>
    <item>
      <title>Forest Reaches New 52-Week High (FRX)</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11923037/1/forest-reaches-new-52-week-high-frx.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Tue, 14 May 2013 11:59:00 GMT</pubDate>
    </item>
    <item>
      <title>Forest-Trevena Ink Deal - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/99329/forest-trevena-ink-deal.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Tue, 14 May 2013 11:40:01 GMT</pubDate>
    </item>
    <item>
      <title>Ironwood and Forest to Present Linaclotide Data at Digestive Disease Week® 2013</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/14/ironwood-and-forest-to-present-linaclotide-data-at/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 14 May 2013 08:36:05 GMT</pubDate>
    </item>
    <item>
      <title>Analysts' Actions: MU BSX CVC FRX</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11919879/1/analysts-actions-mu-bsx-cvc-frx.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Fri, 10 May 2013 08:45:00 GMT</pubDate>
    </item>
    <item>
      <title>Trevena Inc. and Forest Laboratories Announce a Collaborative Agreement for Development of TRV027 fo</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/09/trevena-inc-and-forest-laboratories-announce-a-col/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 09 May 2013 06:18:00 GMT</pubDate>
    </item>
    <item>
      <title>Positive Data on Forest Combo Drug - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98873/positive-data-on-forest-combo-drug.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Tue, 07 May 2013 16:00:01 GMT</pubDate>
    </item>
    <item>
      <title>Take a Deep Breath Before This Big FDA Decision</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/05/take-a-deep-breath-before-this-big-fda-decision/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sun, 05 May 2013 14:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Mylan Reports in line Earnings - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98558/mylan-reports-in-line-earnings.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Fri, 03 May 2013 07:55:01 GMT</pubDate>
    </item>
    <item>
      <title>Forest Laboratories and Almirall Announce Positive Results for the Second Phase III Study for Aclidi</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/01/forest-laboratories-and-almirall-announce-positive/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 01 May 2013 14:34:24 GMT</pubDate>
    </item>
    <item>
      <title>Forest Laboratories and Almirall Announce Positive Results for the Second Phase III Study for Aclidi</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3549411/forest-laboratories-and-almirall-announce-positive-results-for-the-second-phase-i.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 01 May 2013 14:18:01 GMT</pubDate>
    </item>
    <item>
      <title>3 Horrendous Health-Care Stocks This Week</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/27/3-horrendous-health-care-stocks-this-week-25/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 27 Apr 2013 07:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Synergy On Sale: Why This Opportunity Shouldn't Be Missed</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1370861-synergy-on-sale-why-this-opportunity-shouldn-t-be-missed.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 25 Apr 2013 11:46:45 GMT</pubDate>
    </item>
    <item>
      <title>Loss Widens at Ironwood  - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97831/loss-widens-at-ironwood.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Wed, 24 Apr 2013 16:00:01 GMT</pubDate>
    </item>
    <item>
      <title>Forest Laboratories Management Discusses Q4 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1363111-forest-laboratories-management-discusses-q4-2013-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 23 Apr 2013 15:40:06 GMT</pubDate>
    </item>
    <item>
      <title>Bill Nygren Comments on Forest Laboratories</title>
      <link>http://www.fool.com/news/xt/gurufocus/www.gurufocus.com/news/217247/bill-nygren-comments-on-forest-laboratories.aspx?source=itxwebtxt0000015</link>
      <author>GuruFocus</author>
      <pubDate>Tue, 23 Apr 2013 14:12:25 GMT</pubDate>
    </item>
    <item>
      <title>Forest Labs' Earnings Decline - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97708/forest-labs-earnings-decline.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Tue, 23 Apr 2013 14:10:01 GMT</pubDate>
    </item>
    <item>
      <title>Ironwood's Constipation Drug Sales Disappoint</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11902530/1/ironwoods-constipation-drug-sales-disappoint.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Tue, 23 Apr 2013 08:18:00 GMT</pubDate>
    </item>
  </channel>
</rss>
